TickerFacts.

OS Therapies Inc (OSTX): Operating Income

Annual figures by period end, from SEC filings.

-$28.71M
Year ended 2025-12-31
-$37.61M
Trailing 12 months to 2026-06-30
2023-12-31: -$4.34M2024-12-31: -$6.81M2025-12-31: -$28.71M-$28.71M
2023-12-31 Operating Income (USD) 2025-12-31
Period endedOperating IncomeChange YoYSource filing
2025-12-31-$28.71Mn/m2026-03-31, From 2025-01-01
2024-12-31-$6.81Mn/m2026-03-31, From 2024-01-01
2023-12-31-$4.34Mn/a2025-03-31, From 2023-01-01

Operating Income at similar companies

Companies with the same SEC industry code (Pharmaceutical Preparations), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedOperating IncomeChange YoY
OS Therapies Inc (OSTX)2025-12-31-$28.71Mn/m
Serina Therapeutics, Inc. (SER)2025-12-31-$24.02Mn/m
CV Sciences, Inc. (CVSI)2025-12-31-$470.0Kn/m
Adial Pharmaceuticals, Inc. (ADIL)2025-12-31-$7.80Mn/m
Cannapharmarx, Inc. (CPMD)2025-12-31-$3.35Mn/m
Kairos Pharma, Ltd. (KAPA)2025-12-31-$5.57Mn/m
Vyome Holdings, Inc (HIND)2025-12-31-$10.45Mn/m
Matinas BioPharma Holdings, Inc. (MTNB)2025-12-31-$6.96Mn/m
GeoVax Labs, Inc. (GOVX)2025-12-31-$21.64Mn/m

Compare OSTX, SER, CVSI, ADIL side by side · Screen every company in Pharmaceutical Preparations ↗